nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—SLC22A3—prostate cancer	0.244	0.46	CbGaD
Norepinephrine—SLC22A1—prostate cancer	0.175	0.33	CbGaD
Norepinephrine—ADRB2—prostate cancer	0.112	0.21	CbGaD
Norepinephrine—SLC22A3—Estradiol—prostate cancer	0.0617	0.298	CbGbCtD
Norepinephrine—SLC22A2—Estradiol—prostate cancer	0.0365	0.176	CbGbCtD
Norepinephrine—SLC22A1—Estradiol—prostate cancer	0.0317	0.153	CbGbCtD
Norepinephrine—CYP1A2—Flutamide—prostate cancer	0.0268	0.129	CbGbCtD
Norepinephrine—CYP1A2—Estrone—prostate cancer	0.0194	0.0935	CbGbCtD
Norepinephrine—ADRA1B—vas deferens—prostate cancer	0.0178	0.328	CbGeAlD
Norepinephrine—CYP1A2—Conjugated Estrogens—prostate cancer	0.0127	0.0611	CbGbCtD
Norepinephrine—CYP1A2—Estradiol—prostate cancer	0.0111	0.0537	CbGbCtD
Norepinephrine—CYP1A2—Etoposide—prostate cancer	0.00726	0.035	CbGbCtD
Norepinephrine—ADRB3—prostate gland—prostate cancer	0.00277	0.0509	CbGeAlD
Norepinephrine—PAH—renal system—prostate cancer	0.00241	0.0444	CbGeAlD
Norepinephrine—Blood pressure increased—Estrone—prostate cancer	0.00216	0.0318	CcSEcCtD
Norepinephrine—CYP1A2—urine—prostate cancer	0.00206	0.0379	CbGeAlD
Norepinephrine—Blood pressure increased—Estradiol valerate/Dienogest—prostate cancer	0.00189	0.0278	CcSEcCtD
Norepinephrine—Photophobia—Nilutamide—prostate cancer	0.00188	0.0278	CcSEcCtD
Norepinephrine—SLC18A2—prostate gland—prostate cancer	0.00158	0.029	CbGeAlD
Norepinephrine—SLC18A1—lymph node—prostate cancer	0.00158	0.029	CbGeAlD
Norepinephrine—ADRA1D—prostate gland—prostate cancer	0.00156	0.0286	CbGeAlD
Norepinephrine—Lactic acidosis—Epirubicin—prostate cancer	0.00142	0.0209	CcSEcCtD
Norepinephrine—Lactic acidosis—Doxorubicin—prostate cancer	0.00132	0.0194	CcSEcCtD
Norepinephrine—Blood pressure increased—Ethinyl Estradiol—prostate cancer	0.00123	0.018	CcSEcCtD
Norepinephrine—Extravasation—Goserelin—prostate cancer	0.00116	0.017	CcSEcCtD
Norepinephrine—Extravasation—Conjugated Estrogens—prostate cancer	0.00114	0.0169	CcSEcCtD
Norepinephrine—ADRA1D—epithelium—prostate cancer	0.00114	0.021	CbGeAlD
Norepinephrine—SLC22A2—renal system—prostate cancer	0.00113	0.0208	CbGeAlD
Norepinephrine—ADRB1—prostate gland—prostate cancer	0.00113	0.0208	CbGeAlD
Norepinephrine—SLC22A3—prostate gland—prostate cancer	0.00112	0.0207	CbGeAlD
Norepinephrine—ADRA1B—renal system—prostate cancer	0.00109	0.02	CbGeAlD
Norepinephrine—Sweating—Nilutamide—prostate cancer	0.00108	0.0159	CcSEcCtD
Norepinephrine—ADRA1D—urethra—prostate cancer	0.00104	0.0192	CbGeAlD
Norepinephrine—Blood pressure increased—Conjugated Estrogens—prostate cancer	0.000999	0.0147	CcSEcCtD
Norepinephrine—Arrhythmia—Abiraterone—prostate cancer	0.000986	0.0145	CcSEcCtD
Norepinephrine—SLC22A3—seminal vesicle—prostate cancer	0.00095	0.0175	CbGeAlD
Norepinephrine—ADRA1A—prostate gland—prostate cancer	0.000894	0.0165	CbGeAlD
Norepinephrine—Retrosternal pain—Epirubicin—prostate cancer	0.000862	0.0127	CcSEcCtD
Norepinephrine—Extravasation—Mitoxantrone—prostate cancer	0.000854	0.0126	CcSEcCtD
Norepinephrine—ADRA2C—prostate gland—prostate cancer	0.000852	0.0157	CbGeAlD
Norepinephrine—Chest pain—Estramustine—prostate cancer	0.000842	0.0124	CcSEcCtD
Norepinephrine—Anxiety—Estramustine—prostate cancer	0.000839	0.0124	CcSEcCtD
Norepinephrine—Hypertension—Abiraterone—prostate cancer	0.000829	0.0122	CcSEcCtD
Norepinephrine—Chest pain—Abiraterone—prostate cancer	0.000818	0.012	CcSEcCtD
Norepinephrine—SLC22A5—prostate gland—prostate cancer	0.000816	0.015	CbGeAlD
Norepinephrine—Arrhythmia—Degarelix—prostate cancer	0.000805	0.0119	CcSEcCtD
Norepinephrine—SLC22A1—renal system—prostate cancer	0.000801	0.0147	CbGeAlD
Norepinephrine—Blood pressure increased—Estradiol—prostate cancer	0.000799	0.0118	CcSEcCtD
Norepinephrine—Retrosternal pain—Doxorubicin—prostate cancer	0.000798	0.0118	CcSEcCtD
Norepinephrine—Sweating—Bicalutamide—prostate cancer	0.000777	0.0114	CcSEcCtD
Norepinephrine—SLC22A3—renal system—prostate cancer	0.000765	0.0141	CbGeAlD
Norepinephrine—Arrhythmia—Cabazitaxel—prostate cancer	0.000758	0.0112	CcSEcCtD
Norepinephrine—Hypertension—Nilutamide—prostate cancer	0.000758	0.0112	CcSEcCtD
Norepinephrine—Hypertension—Flutamide—prostate cancer	0.000754	0.0111	CcSEcCtD
Norepinephrine—SLC22A3—urethra—prostate cancer	0.000752	0.0138	CbGeAlD
Norepinephrine—Chest pain—Nilutamide—prostate cancer	0.000747	0.011	CcSEcCtD
Norepinephrine—Anxiety—Flutamide—prostate cancer	0.000741	0.0109	CcSEcCtD
Norepinephrine—Bradycardia—Bicalutamide—prostate cancer	0.000741	0.0109	CcSEcCtD
Norepinephrine—ADRA2C—seminal vesicle—prostate cancer	0.000721	0.0133	CbGeAlD
Norepinephrine—Dyspnoea—Estramustine—prostate cancer	0.00072	0.0106	CcSEcCtD
Norepinephrine—Extravasation—Etoposide—prostate cancer	0.00071	0.0105	CcSEcCtD
Norepinephrine—Anxiety—Estradiol valerate/Dienogest—prostate cancer	0.0007	0.0103	CcSEcCtD
Norepinephrine—Dyspnoea—Abiraterone—prostate cancer	0.000699	0.0103	CcSEcCtD
Norepinephrine—SLC18A2—testis—prostate cancer	0.000695	0.0128	CbGeAlD
Norepinephrine—Hyperhidrosis—Nilutamide—prostate cancer	0.000692	0.0102	CcSEcCtD
Norepinephrine—SLC22A5—seminal vesicle—prostate cancer	0.00069	0.0127	CbGeAlD
Norepinephrine—ADRA2A—prostate gland—prostate cancer	0.00068	0.0125	CbGeAlD
Norepinephrine—Hypertension—Degarelix—prostate cancer	0.000677	0.00997	CcSEcCtD
Norepinephrine—ADRA1A—epithelium—prostate cancer	0.000657	0.0121	CbGeAlD
Norepinephrine—Arrhythmia—Bicalutamide—prostate cancer	0.00065	0.00958	CcSEcCtD
Norepinephrine—Dyspnoea—Nilutamide—prostate cancer	0.000639	0.00941	CcSEcCtD
Norepinephrine—Hypertension—Cabazitaxel—prostate cancer	0.000638	0.00939	CcSEcCtD
Norepinephrine—Chest pain—Cabazitaxel—prostate cancer	0.000629	0.00926	CcSEcCtD
Norepinephrine—Anxiety—Cabazitaxel—prostate cancer	0.000627	0.00923	CcSEcCtD
Norepinephrine—Hyperhidrosis—Degarelix—prostate cancer	0.000619	0.00911	CcSEcCtD
Norepinephrine—ADRA1A—renal system—prostate cancer	0.00061	0.0112	CbGeAlD
Norepinephrine—Extravasation—Docetaxel—prostate cancer	0.00059	0.00869	CcSEcCtD
Norepinephrine—ADRA2C—renal system—prostate cancer	0.000581	0.0107	CbGeAlD
Norepinephrine—ADRA2A—seminal vesicle—prostate cancer	0.000575	0.0106	CbGeAlD
Norepinephrine—Methyldopa—COMT—prostate cancer	0.000572	0.152	CrCbGaD
Norepinephrine—ADRA2C—urethra—prostate cancer	0.000571	0.0105	CbGeAlD
Norepinephrine—Dyspnoea—Degarelix—prostate cancer	0.00057	0.0084	CcSEcCtD
Norepinephrine—SLC22A5—renal system—prostate cancer	0.000556	0.0102	CbGeAlD
Norepinephrine—Hypertension—Bicalutamide—prostate cancer	0.000547	0.00806	CcSEcCtD
Norepinephrine—SLC22A5—urethra—prostate cancer	0.000547	0.0101	CbGeAlD
Norepinephrine—Sweating—Goserelin—prostate cancer	0.000541	0.00796	CcSEcCtD
Norepinephrine—Chest pain—Bicalutamide—prostate cancer	0.000539	0.00795	CcSEcCtD
Norepinephrine—Anxiety—Bicalutamide—prostate cancer	0.000538	0.00792	CcSEcCtD
Norepinephrine—Dyspnoea—Cabazitaxel—prostate cancer	0.000537	0.00792	CcSEcCtD
Norepinephrine—Blood pressure increased—Docetaxel—prostate cancer	0.000515	0.00758	CcSEcCtD
Norepinephrine—Vomiting—Estramustine—prostate cancer	0.000513	0.00756	CcSEcCtD
Norepinephrine—Headache—Estramustine—prostate cancer	0.000506	0.00745	CcSEcCtD
Norepinephrine—CYP1A2—renal system—prostate cancer	0.000504	0.00927	CbGeAlD
Norepinephrine—SLC18A2—lymph node—prostate cancer	0.000503	0.00926	CbGeAlD
Norepinephrine—Hyperhidrosis—Bicalutamide—prostate cancer	0.0005	0.00736	CcSEcCtD
Norepinephrine—Vomiting—Abiraterone—prostate cancer	0.000498	0.00734	CcSEcCtD
Norepinephrine—Blood pressure increased—Capecitabine—prostate cancer	0.000498	0.00734	CcSEcCtD
Norepinephrine—SLC22A3—testis—prostate cancer	0.000495	0.0091	CbGeAlD
Norepinephrine—Vomiting—Estrone—prostate cancer	0.00049	0.00722	CcSEcCtD
Norepinephrine—Headache—Estrone—prostate cancer	0.000483	0.00712	CcSEcCtD
Norepinephrine—Dyspnoea—Bicalutamide—prostate cancer	0.000461	0.00679	CcSEcCtD
Norepinephrine—Vomiting—Nilutamide—prostate cancer	0.000455	0.00671	CcSEcCtD
Norepinephrine—ADRA2A—urethra—prostate cancer	0.000455	0.00837	CbGeAlD
Norepinephrine—Anxiety—Ethinyl Estradiol—prostate cancer	0.000454	0.00669	CcSEcCtD
Norepinephrine—Vomiting—Flutamide—prostate cancer	0.000453	0.00668	CcSEcCtD
Norepinephrine—Arrhythmia—Goserelin—prostate cancer	0.000452	0.00666	CcSEcCtD
Norepinephrine—Headache—Nilutamide—prostate cancer	0.000449	0.00661	CcSEcCtD
Norepinephrine—Arrhythmia—Conjugated Estrogens—prostate cancer	0.000448	0.0066	CcSEcCtD
Norepinephrine—Headache—Flutamide—prostate cancer	0.000447	0.00658	CcSEcCtD
Norepinephrine—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000428	0.0063	CcSEcCtD
Norepinephrine—SLC6A2—testis—prostate cancer	0.000424	0.0078	CbGeAlD
Norepinephrine—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000422	0.00621	CcSEcCtD
Norepinephrine—Isoetarine—ADRB2—prostate cancer	0.000419	0.111	CrCbGaD
Norepinephrine—Vomiting—Degarelix—prostate cancer	0.000407	0.00599	CcSEcCtD
Norepinephrine—Headache—Degarelix—prostate cancer	0.000401	0.0059	CcSEcCtD
Norepinephrine—Sweating—Mitoxantrone—prostate cancer	0.000399	0.00588	CcSEcCtD
Norepinephrine—Extravasation—Epirubicin—prostate cancer	0.000398	0.00586	CcSEcCtD
Norepinephrine—DRD2—testis—prostate cancer	0.000386	0.0071	CbGeAlD
Norepinephrine—Vomiting—Cabazitaxel—prostate cancer	0.000383	0.00565	CcSEcCtD
Norepinephrine—Bradycardia—Mitoxantrone—prostate cancer	0.000381	0.00561	CcSEcCtD
Norepinephrine—Hypertension—Goserelin—prostate cancer	0.000381	0.00561	CcSEcCtD
Norepinephrine—Headache—Cabazitaxel—prostate cancer	0.000378	0.00556	CcSEcCtD
Norepinephrine—ADRA2C—testis—prostate cancer	0.000375	0.00691	CbGeAlD
Norepinephrine—Chest pain—Goserelin—prostate cancer	0.000375	0.00553	CcSEcCtD
Norepinephrine—Anxiety—Goserelin—prostate cancer	0.000374	0.00551	CcSEcCtD
Norepinephrine—Chest pain—Conjugated Estrogens—prostate cancer	0.000372	0.00547	CcSEcCtD
Norepinephrine—Anxiety—Conjugated Estrogens—prostate cancer	0.00037	0.00546	CcSEcCtD
Norepinephrine—Extravasation—Doxorubicin—prostate cancer	0.000368	0.00542	CcSEcCtD
Norepinephrine—SLC22A5—testis—prostate cancer	0.00036	0.00661	CbGeAlD
Norepinephrine—SLC22A3—lymph node—prostate cancer	0.000359	0.00659	CbGeAlD
Norepinephrine—Hyperhidrosis—Goserelin—prostate cancer	0.000348	0.00512	CcSEcCtD
Norepinephrine—Hyperhidrosis—Conjugated Estrogens—prostate cancer	0.000344	0.00507	CcSEcCtD
Norepinephrine—Arrhythmia—Mitoxantrone—prostate cancer	0.000334	0.00492	CcSEcCtD
Norepinephrine—Arbutamine—ADRB2—prostate cancer	0.000333	0.0885	CrCbGaD
Norepinephrine—Vomiting—Bicalutamide—prostate cancer	0.000329	0.00484	CcSEcCtD
Norepinephrine—Dopamine—SLC22A3—prostate cancer	0.000327	0.0869	CrCbGaD
Norepinephrine—Headache—Bicalutamide—prostate cancer	0.000324	0.00477	CcSEcCtD
Norepinephrine—Salbutamol—ADRB2—prostate cancer	0.000323	0.0859	CrCbGaD
Norepinephrine—Dyspnoea—Goserelin—prostate cancer	0.000321	0.00472	CcSEcCtD
Norepinephrine—Dyspnoea—Conjugated Estrogens—prostate cancer	0.000318	0.00468	CcSEcCtD
Norepinephrine—SLC6A2—lymph node—prostate cancer	0.000307	0.00565	CbGeAlD
Norepinephrine—Hypertension—Estradiol—prostate cancer	0.000302	0.00444	CcSEcCtD
Norepinephrine—ADRA2A—testis—prostate cancer	0.0003	0.00551	CbGeAlD
Norepinephrine—Chest pain—Estradiol—prostate cancer	0.000297	0.00438	CcSEcCtD
Norepinephrine—Anxiety—Estradiol—prostate cancer	0.000296	0.00437	CcSEcCtD
Norepinephrine—Hypertension—Mitoxantrone—prostate cancer	0.000281	0.00414	CcSEcCtD
Norepinephrine—Dopamine—COMT—prostate cancer	0.000279	0.0743	CrCbGaD
Norepinephrine—Vomiting—Ethinyl Estradiol—prostate cancer	0.000278	0.00409	CcSEcCtD
Norepinephrine—Chest pain—Mitoxantrone—prostate cancer	0.000277	0.00408	CcSEcCtD
Norepinephrine—Anxiety—Mitoxantrone—prostate cancer	0.000276	0.00407	CcSEcCtD
Norepinephrine—Hyperhidrosis—Estradiol—prostate cancer	0.000276	0.00406	CcSEcCtD
Norepinephrine—Headache—Ethinyl Estradiol—prostate cancer	0.000274	0.00403	CcSEcCtD
Norepinephrine—ADRA2C—lymph node—prostate cancer	0.000272	0.00501	CbGeAlD
Norepinephrine—SLC22A5—lymph node—prostate cancer	0.000261	0.00479	CbGeAlD
Norepinephrine—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000257	0.00378	CcSEcCtD
Norepinephrine—Bradycardia—Capecitabine—prostate cancer	0.000255	0.00375	CcSEcCtD
Norepinephrine—Dyspnoea—Estradiol—prostate cancer	0.000254	0.00374	CcSEcCtD
Norepinephrine—Dyspnoea—Mitoxantrone—prostate cancer	0.000237	0.00349	CcSEcCtD
Norepinephrine—Dopamine—SLC22A1—prostate cancer	0.000234	0.0623	CrCbGaD
Norepinephrine—Hypertension—Etoposide—prostate cancer	0.000234	0.00344	CcSEcCtD
Norepinephrine—Arrhythmia—Docetaxel—prostate cancer	0.000231	0.0034	CcSEcCtD
Norepinephrine—Chest pain—Etoposide—prostate cancer	0.000231	0.0034	CcSEcCtD
Norepinephrine—Epinephrine—SLC22A1—prostate cancer	0.000229	0.0608	CrCbGaD
Norepinephrine—Vomiting—Goserelin—prostate cancer	0.000229	0.00337	CcSEcCtD
Norepinephrine—Bradycardia—Prednisone—prostate cancer	0.000227	0.00334	CcSEcCtD
Norepinephrine—Vomiting—Conjugated Estrogens—prostate cancer	0.000227	0.00334	CcSEcCtD
Norepinephrine—Headache—Goserelin—prostate cancer	0.000225	0.00332	CcSEcCtD
Norepinephrine—Arrhythmia—Capecitabine—prostate cancer	0.000224	0.00329	CcSEcCtD
Norepinephrine—Headache—Conjugated Estrogens—prostate cancer	0.000223	0.00329	CcSEcCtD
Norepinephrine—ADRA2A—lymph node—prostate cancer	0.000217	0.00399	CbGeAlD
Norepinephrine—Hyperhidrosis—Etoposide—prostate cancer	0.000214	0.00315	CcSEcCtD
Norepinephrine—Arrhythmia—Prednisone—prostate cancer	0.000199	0.00293	CcSEcCtD
Norepinephrine—Dyspnoea—Etoposide—prostate cancer	0.000197	0.0029	CcSEcCtD
Norepinephrine—Hypertension—Docetaxel—prostate cancer	0.000194	0.00286	CcSEcCtD
Norepinephrine—Chest pain—Docetaxel—prostate cancer	0.000192	0.00282	CcSEcCtD
Norepinephrine—Droxidopa—ADRB2—prostate cancer	0.000191	0.0508	CrCbGaD
Norepinephrine—Hypertension—Capecitabine—prostate cancer	0.000188	0.00277	CcSEcCtD
Norepinephrine—Sweating—Epirubicin—prostate cancer	0.000186	0.00274	CcSEcCtD
Norepinephrine—Chest pain—Capecitabine—prostate cancer	0.000185	0.00273	CcSEcCtD
Norepinephrine—Anxiety—Capecitabine—prostate cancer	0.000185	0.00272	CcSEcCtD
Norepinephrine—Vomiting—Estradiol—prostate cancer	0.000181	0.00267	CcSEcCtD
Norepinephrine—Headache—Estradiol—prostate cancer	0.000179	0.00263	CcSEcCtD
Norepinephrine—Bradycardia—Epirubicin—prostate cancer	0.000178	0.00261	CcSEcCtD
Norepinephrine—Salbutamol—CYP3A4—prostate cancer	0.000177	0.047	CrCbGaD
Norepinephrine—Isoprenaline—ADRB2—prostate cancer	0.000174	0.0462	CrCbGaD
Norepinephrine—Sweating—Doxorubicin—prostate cancer	0.000172	0.00254	CcSEcCtD
Norepinephrine—Hyperhidrosis—Capecitabine—prostate cancer	0.000172	0.00253	CcSEcCtD
Norepinephrine—Vomiting—Mitoxantrone—prostate cancer	0.000169	0.00249	CcSEcCtD
Norepinephrine—Hypertension—Prednisone—prostate cancer	0.000168	0.00247	CcSEcCtD
Norepinephrine—Headache—Mitoxantrone—prostate cancer	0.000166	0.00245	CcSEcCtD
Norepinephrine—Anxiety—Prednisone—prostate cancer	0.000165	0.00243	CcSEcCtD
Norepinephrine—Bradycardia—Doxorubicin—prostate cancer	0.000164	0.00242	CcSEcCtD
Norepinephrine—Dyspnoea—Docetaxel—prostate cancer	0.000164	0.00241	CcSEcCtD
Norepinephrine—Dyspnoea—Capecitabine—prostate cancer	0.000159	0.00234	CcSEcCtD
Norepinephrine—Arrhythmia—Epirubicin—prostate cancer	0.000156	0.00229	CcSEcCtD
Norepinephrine—Hyperhidrosis—Prednisone—prostate cancer	0.000153	0.00226	CcSEcCtD
Norepinephrine—Isoprenaline—CYP1A1—prostate cancer	0.000149	0.0396	CrCbGaD
Norepinephrine—Epinephrine—ADRB2—prostate cancer	0.000146	0.0388	CrCbGaD
Norepinephrine—Arrhythmia—Doxorubicin—prostate cancer	0.000144	0.00212	CcSEcCtD
Norepinephrine—Vomiting—Etoposide—prostate cancer	0.000141	0.00207	CcSEcCtD
Norepinephrine—Headache—Etoposide—prostate cancer	0.000138	0.00204	CcSEcCtD
Norepinephrine—Hypertension—Epirubicin—prostate cancer	0.000131	0.00193	CcSEcCtD
Norepinephrine—Chest pain—Epirubicin—prostate cancer	0.000129	0.0019	CcSEcCtD
Norepinephrine—Anxiety—Epirubicin—prostate cancer	0.000129	0.0019	CcSEcCtD
Norepinephrine—Dopamine—CYP2C19—prostate cancer	0.000129	0.0342	CrCbGaD
Norepinephrine—Hypertension—Doxorubicin—prostate cancer	0.000121	0.00179	CcSEcCtD
Norepinephrine—Hyperhidrosis—Epirubicin—prostate cancer	0.00012	0.00176	CcSEcCtD
Norepinephrine—Chest pain—Doxorubicin—prostate cancer	0.00012	0.00176	CcSEcCtD
Norepinephrine—Anxiety—Doxorubicin—prostate cancer	0.000119	0.00176	CcSEcCtD
Norepinephrine—Vomiting—Docetaxel—prostate cancer	0.000117	0.00172	CcSEcCtD
Norepinephrine—Headache—Docetaxel—prostate cancer	0.000115	0.00169	CcSEcCtD
Norepinephrine—Vomiting—Capecitabine—prostate cancer	0.000113	0.00167	CcSEcCtD
Norepinephrine—Headache—Capecitabine—prostate cancer	0.000111	0.00164	CcSEcCtD
Norepinephrine—Hyperhidrosis—Doxorubicin—prostate cancer	0.000111	0.00163	CcSEcCtD
Norepinephrine—Dyspnoea—Epirubicin—prostate cancer	0.00011	0.00163	CcSEcCtD
Norepinephrine—Dyspnoea—Doxorubicin—prostate cancer	0.000102	0.00151	CcSEcCtD
Norepinephrine—Vomiting—Prednisone—prostate cancer	0.000101	0.00148	CcSEcCtD
Norepinephrine—Headache—Prednisone—prostate cancer	9.92e-05	0.00146	CcSEcCtD
Norepinephrine—Epinephrine—CYP3A4—prostate cancer	7.99e-05	0.0212	CrCbGaD
Norepinephrine—Vomiting—Epirubicin—prostate cancer	7.88e-05	0.00116	CcSEcCtD
Norepinephrine—Headache—Epirubicin—prostate cancer	7.76e-05	0.00114	CcSEcCtD
Norepinephrine—Vomiting—Doxorubicin—prostate cancer	7.29e-05	0.00107	CcSEcCtD
Norepinephrine—Headache—Doxorubicin—prostate cancer	7.18e-05	0.00106	CcSEcCtD
Norepinephrine—ADRA1D—Signaling Pathways—EP300—prostate cancer	1.82e-06	1.33e-05	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—AKT1—prostate cancer	1.82e-06	1.33e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CASP3—prostate cancer	1.81e-06	1.33e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PIK3CB—prostate cancer	1.81e-06	1.32e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL2—prostate cancer	1.81e-06	1.32e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IGF1—prostate cancer	1.81e-06	1.32e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CCND1—prostate cancer	1.8e-06	1.32e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—IL6—prostate cancer	1.8e-06	1.32e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—EGFR—prostate cancer	1.8e-06	1.32e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PTGS2—prostate cancer	1.79e-06	1.31e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CXCL8—prostate cancer	1.79e-06	1.31e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—FGF2—prostate cancer	1.79e-06	1.31e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CCND1—prostate cancer	1.79e-06	1.31e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CTNNB1—prostate cancer	1.79e-06	1.31e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—JAK2—prostate cancer	1.78e-06	1.3e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—TYMS—prostate cancer	1.78e-06	1.3e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—SRC—prostate cancer	1.77e-06	1.3e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CTNNB1—prostate cancer	1.77e-06	1.29e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NOS3—prostate cancer	1.77e-06	1.29e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCND1—prostate cancer	1.76e-06	1.29e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CXCL8—prostate cancer	1.76e-06	1.29e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—EP300—prostate cancer	1.76e-06	1.29e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GSTM1—prostate cancer	1.76e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MMP9—prostate cancer	1.75e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CDKN1B—prostate cancer	1.75e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MAP2K1—prostate cancer	1.75e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CTNNB1—prostate cancer	1.75e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—PIK3CA—prostate cancer	1.75e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CDKN1A—prostate cancer	1.75e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PTEN—prostate cancer	1.74e-06	1.27e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MDM2—prostate cancer	1.74e-06	1.27e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CD—prostate cancer	1.74e-06	1.27e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MMP9—prostate cancer	1.74e-06	1.27e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—AKT1—prostate cancer	1.73e-06	1.27e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CDKN1A—prostate cancer	1.73e-06	1.26e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—VEGFA—prostate cancer	1.73e-06	1.26e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—LPL—prostate cancer	1.73e-06	1.26e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PTEN—prostate cancer	1.73e-06	1.26e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CDKN1B—prostate cancer	1.72e-06	1.26e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—PIK3CA—prostate cancer	1.72e-06	1.26e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SERPINE1—prostate cancer	1.72e-06	1.26e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—JAK2—prostate cancer	1.72e-06	1.25e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CASP3—prostate cancer	1.72e-06	1.25e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—ERBB2—prostate cancer	1.71e-06	1.25e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MMP9—prostate cancer	1.71e-06	1.25e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL2—prostate cancer	1.71e-06	1.25e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—STAT3—prostate cancer	1.71e-06	1.25e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CDKN1A—prostate cancer	1.71e-06	1.25e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—IL6—prostate cancer	1.7e-06	1.25e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—AKT1—prostate cancer	1.7e-06	1.25e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PTEN—prostate cancer	1.7e-06	1.25e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—KRAS—prostate cancer	1.7e-06	1.24e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—AKT1—prostate cancer	1.7e-06	1.24e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PIK3CB—prostate cancer	1.69e-06	1.24e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—AKT1—prostate cancer	1.69e-06	1.24e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CASP3—prostate cancer	1.69e-06	1.23e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL2—prostate cancer	1.69e-06	1.23e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—AKT1—prostate cancer	1.68e-06	1.23e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—PIK3CA—prostate cancer	1.68e-06	1.23e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—IL6—prostate cancer	1.68e-06	1.23e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MDM2—prostate cancer	1.68e-06	1.23e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCND1—prostate cancer	1.67e-06	1.22e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.67e-06	1.22e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—FGF2—prostate cancer	1.66e-06	1.22e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—AKT1—prostate cancer	1.66e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—EP300—prostate cancer	1.66e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CTNNB1—prostate cancer	1.65e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ERCC2—prostate cancer	1.65e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—ERBB2—prostate cancer	1.65e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—EP300—prostate cancer	1.65e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCND1—prostate cancer	1.64e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NOS3—prostate cancer	1.64e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PIK3CB—prostate cancer	1.63e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CTNNB1—prostate cancer	1.63e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CXCL8—prostate cancer	1.63e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—EP300—prostate cancer	1.62e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MMP9—prostate cancer	1.62e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CDKN1A—prostate cancer	1.62e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—SRC—prostate cancer	1.61e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PTEN—prostate cancer	1.61e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—SRC—prostate cancer	1.6e-06	1.17e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MMP9—prostate cancer	1.6e-06	1.17e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—JAK2—prostate cancer	1.59e-06	1.17e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CDKN1A—prostate cancer	1.59e-06	1.16e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CDKN1B—prostate cancer	1.59e-06	1.16e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MYC—prostate cancer	1.59e-06	1.16e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PTEN—prostate cancer	1.59e-06	1.16e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TGFB1—prostate cancer	1.58e-06	1.16e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—SRC—prostate cancer	1.58e-06	1.15e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—VEGFA—prostate cancer	1.57e-06	1.15e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—AKT1—prostate cancer	1.57e-06	1.15e-05	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—AKT1—prostate cancer	1.57e-06	1.15e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CXCL8—prostate cancer	1.57e-06	1.15e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PTEN—prostate cancer	1.57e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—PIK3CA—prostate cancer	1.56e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—VEGFA—prostate cancer	1.56e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—STAT3—prostate cancer	1.56e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MDM2—prostate cancer	1.56e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CASP3—prostate cancer	1.56e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL2—prostate cancer	1.55e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—MTHFR—prostate cancer	1.55e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—EGFR—prostate cancer	1.55e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—AKT1—prostate cancer	1.55e-06	1.13e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—IL6—prostate cancer	1.55e-06	1.13e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—STAT3—prostate cancer	1.54e-06	1.13e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—VEGFA—prostate cancer	1.54e-06	1.12e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—EP300—prostate cancer	1.54e-06	1.12e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—ERBB2—prostate cancer	1.53e-06	1.12e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CDKN1B—prostate cancer	1.53e-06	1.12e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PPARA—prostate cancer	1.52e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—STAT3—prostate cancer	1.52e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCND1—prostate cancer	1.51e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CB—prostate cancer	1.51e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—AKT1—prostate cancer	1.51e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—EP300—prostate cancer	1.51e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CTNNB1—prostate cancer	1.5e-06	1.1e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CASP3—prostate cancer	1.5e-06	1.1e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL2—prostate cancer	1.5e-06	1.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—SRC—prostate cancer	1.49e-06	1.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—EP300—prostate cancer	1.49e-06	1.09e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—IL6—prostate cancer	1.49e-06	1.09e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—SRC—prostate cancer	1.47e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MMP9—prostate cancer	1.47e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—KRAS—prostate cancer	1.47e-06	1.07e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CDKN1A—prostate cancer	1.47e-06	1.07e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PTEN—prostate cancer	1.46e-06	1.07e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCND1—prostate cancer	1.46e-06	1.07e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CXCL8—prostate cancer	1.46e-06	1.06e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—VEGFA—prostate cancer	1.46e-06	1.06e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MYC—prostate cancer	1.45e-06	1.06e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CTNNB1—prostate cancer	1.45e-06	1.06e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TGFB1—prostate cancer	1.44e-06	1.06e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—STAT3—prostate cancer	1.44e-06	1.05e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MYC—prostate cancer	1.43e-06	1.05e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CAV1—prostate cancer	1.43e-06	1.05e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—VEGFA—prostate cancer	1.43e-06	1.05e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TGFB1—prostate cancer	1.43e-06	1.05e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—AKT1—prostate cancer	1.43e-06	1.04e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CDKN1B—prostate cancer	1.42e-06	1.04e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—STAT3—prostate cancer	1.42e-06	1.04e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MMP9—prostate cancer	1.42e-06	1.04e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MYC—prostate cancer	1.42e-06	1.03e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—EGFR—prostate cancer	1.42e-06	1.03e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CDKN1A—prostate cancer	1.41e-06	1.03e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TGFB1—prostate cancer	1.41e-06	1.03e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PTEN—prostate cancer	1.41e-06	1.03e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—AKT1—prostate cancer	1.41e-06	1.03e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—EGFR—prostate cancer	1.4e-06	1.03e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—PIK3CA—prostate cancer	1.4e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—EP300—prostate cancer	1.39e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CASP3—prostate cancer	1.39e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL2—prostate cancer	1.39e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—EGFR—prostate cancer	1.38e-06	1.01e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—IL6—prostate cancer	1.38e-06	1.01e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—AKT1—prostate cancer	1.37e-06	1e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.37e-06	1e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—PIK3CA—prostate cancer	1.36e-06	9.94e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCND1—prostate cancer	1.36e-06	9.91e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SRC—prostate cancer	1.36e-06	9.91e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—PIK3CA—prostate cancer	1.35e-06	9.86e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—EP300—prostate cancer	1.34e-06	9.82e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CTNNB1—prostate cancer	1.34e-06	9.82e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MYC—prostate cancer	1.34e-06	9.79e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—KRAS—prostate cancer	1.34e-06	9.77e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TGFB1—prostate cancer	1.34e-06	9.77e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—KRAS—prostate cancer	1.32e-06	9.68e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—VEGFA—prostate cancer	1.32e-06	9.66e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MYC—prostate cancer	1.32e-06	9.64e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MMP9—prostate cancer	1.32e-06	9.63e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TGFB1—prostate cancer	1.31e-06	9.61e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CDKN1A—prostate cancer	1.31e-06	9.59e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—EGFR—prostate cancer	1.31e-06	9.58e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PTEN—prostate cancer	1.31e-06	9.57e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—KRAS—prostate cancer	1.31e-06	9.56e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—STAT3—prostate cancer	1.31e-06	9.56e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SRC—prostate cancer	1.31e-06	9.55e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.31e-06	9.54e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TP53—prostate cancer	1.3e-06	9.53e-06	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—PIK3CA—prostate cancer	1.3e-06	9.53e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—EGFR—prostate cancer	1.29e-06	9.42e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—AKT1—prostate cancer	1.28e-06	9.34e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—VEGFA—prostate cancer	1.27e-06	9.3e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—STAT3—prostate cancer	1.26e-06	9.21e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—EP300—prostate cancer	1.25e-06	9.13e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—KRAS—prostate cancer	1.24e-06	9.05e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—INS—prostate cancer	1.24e-06	9.03e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PIK3CA—prostate cancer	1.23e-06	8.98e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—KRAS—prostate cancer	1.22e-06	8.9e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PIK3CA—prostate cancer	1.22e-06	8.9e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MYC—prostate cancer	1.22e-06	8.88e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SRC—prostate cancer	1.21e-06	8.87e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TGFB1—prostate cancer	1.21e-06	8.86e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CREBBP—prostate cancer	1.21e-06	8.85e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PIK3CA—prostate cancer	1.2e-06	8.78e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IL6—prostate cancer	1.19e-06	8.73e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—EGFR—prostate cancer	1.19e-06	8.69e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TP53—prostate cancer	1.19e-06	8.69e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—VEGFA—prostate cancer	1.18e-06	8.64e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TP53—prostate cancer	1.18e-06	8.61e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MYC—prostate cancer	1.17e-06	8.56e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—STAT3—prostate cancer	1.17e-06	8.56e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TGFB1—prostate cancer	1.17e-06	8.54e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TP53—prostate cancer	1.16e-06	8.5e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.15e-06	8.39e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—EGFR—prostate cancer	1.15e-06	8.37e-06	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—AKT1—prostate cancer	1.14e-06	8.35e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PIK3CA—prostate cancer	1.14e-06	8.31e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—KRAS—prostate cancer	1.12e-06	8.21e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PIK3CA—prostate cancer	1.12e-06	8.18e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—AKT1—prostate cancer	1.11e-06	8.12e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PIK3CA—prostate cancer	1.1e-06	8.07e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—AKT1—prostate cancer	1.1e-06	8.05e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TP53—prostate cancer	1.1e-06	8.04e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MYC—prostate cancer	1.09e-06	7.95e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL6—prostate cancer	1.09e-06	7.95e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TGFB1—prostate cancer	1.09e-06	7.93e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—NOS3—prostate cancer	1.08e-06	7.92e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TP53—prostate cancer	1.08e-06	7.91e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—KRAS—prostate cancer	1.08e-06	7.91e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL6—prostate cancer	1.08e-06	7.88e-06	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—AKT1—prostate cancer	1.06e-06	7.78e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL6—prostate cancer	1.06e-06	7.78e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—EGFR—prostate cancer	1.06e-06	7.78e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PIK3CA—prostate cancer	1.03e-06	7.54e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL6—prostate cancer	1.01e-06	7.36e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—KRAS—prostate cancer	1.01e-06	7.35e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—AKT1—prostate cancer	1e-06	7.34e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CB—prostate cancer	1e-06	7.31e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TP53—prostate cancer	9.98e-07	7.3e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—AKT1—prostate cancer	9.94e-07	7.27e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PIK3CA—prostate cancer	9.94e-07	7.27e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PTGS2—prostate cancer	9.91e-07	7.24e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL6—prostate cancer	9.91e-07	7.24e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—AKT1—prostate cancer	9.82e-07	7.18e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TP53—prostate cancer	9.61e-07	7.03e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—AKT1—prostate cancer	9.29e-07	6.79e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CA—prostate cancer	9.23e-07	6.75e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—AKT1—prostate cancer	9.14e-07	6.68e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL6—prostate cancer	9.13e-07	6.68e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—AKT1—prostate cancer	9.02e-07	6.6e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TP53—prostate cancer	8.93e-07	6.53e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL6—prostate cancer	8.8e-07	6.43e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PTEN—prostate cancer	8.64e-07	6.32e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—AKT1—prostate cancer	8.43e-07	6.16e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—EP300—prostate cancer	8.24e-07	6.02e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL6—prostate cancer	8.18e-07	5.98e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AKT1—prostate cancer	8.12e-07	5.94e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AKT1—prostate cancer	7.54e-07	5.51e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CA—prostate cancer	6.1e-07	4.46e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—AKT1—prostate cancer	4.98e-07	3.64e-06	CbGpPWpGaD
